MetaCap

Pasithea Therapeutics (KTTA) News

NASDAQ: KTTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.4787-0.0023 (-0.48%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KTTA news summary

We found 5 recent headlines mentioning Pasithea Therapeutics (KTTA): 1 in the past week and 4 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, KTTA is down 0.48% at $0.4787. The most recent story, "Pasithea Therapeutics Corp. Reports Initial Phase 1/1b Data for PAS-004 and FDA Clearance of IND for Phase 2 Trial", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Pasithea Therapeutics headlines

Stocks mentioned alongside KTTA

Compare KTTA